The presence of coronary artery disease (CAD) in patients undergoing transcatheter aortic valve replacement (TAVR) is associated with significantly worse 5-year outcomes. However, angiography-guided percutaneous coronary intervention (PCI) did not improve outcomes, according to new prospective data.